1. Home
  2. FOXF vs AKRO Comparison

FOXF vs AKRO Comparison

Compare FOXF & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXF
  • AKRO
  • Stock Information
  • Founded
  • FOXF 2007
  • AKRO 2017
  • Country
  • FOXF United States
  • AKRO United States
  • Employees
  • FOXF N/A
  • AKRO N/A
  • Industry
  • FOXF Motor Vehicles
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXF Consumer Discretionary
  • AKRO Health Care
  • Exchange
  • FOXF Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • FOXF 1.6B
  • AKRO 2.1B
  • IPO Year
  • FOXF N/A
  • AKRO 2019
  • Fundamental
  • Price
  • FOXF $37.00
  • AKRO $31.59
  • Analyst Decision
  • FOXF Hold
  • AKRO Strong Buy
  • Analyst Count
  • FOXF 6
  • AKRO 7
  • Target Price
  • FOXF $46.17
  • AKRO $43.20
  • AVG Volume (30 Days)
  • FOXF 293.5K
  • AKRO 441.5K
  • Earning Date
  • FOXF 10-31-2024
  • AKRO 11-11-2024
  • Dividend Yield
  • FOXF N/A
  • AKRO N/A
  • EPS Growth
  • FOXF N/A
  • AKRO N/A
  • EPS
  • FOXF 0.98
  • AKRO N/A
  • Revenue
  • FOXF $1,345,575,000.00
  • AKRO N/A
  • Revenue This Year
  • FOXF N/A
  • AKRO N/A
  • Revenue Next Year
  • FOXF $10.04
  • AKRO N/A
  • P/E Ratio
  • FOXF $37.96
  • AKRO N/A
  • Revenue Growth
  • FOXF N/A
  • AKRO N/A
  • 52 Week Low
  • FOXF $34.56
  • AKRO $11.36
  • 52 Week High
  • FOXF $86.14
  • AKRO $37.00
  • Technical
  • Relative Strength Index (RSI)
  • FOXF 40.65
  • AKRO 66.34
  • Support Level
  • FOXF $36.65
  • AKRO $29.34
  • Resistance Level
  • FOXF $38.36
  • AKRO $32.15
  • Average True Range (ATR)
  • FOXF 1.35
  • AKRO 1.26
  • MACD
  • FOXF -0.21
  • AKRO 0.10
  • Stochastic Oscillator
  • FOXF 20.19
  • AKRO 99.74

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: